{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:43:58Z","timestamp":1790628238860,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Extracorporeal membrane oxygenation is a lifesaving therapy for patients with severe acute respiratory distress syndrome refractory to conventional mechanical ventilation. It is frequently complicated by both thrombosis and hemorrhage. A markedly prothrombotic state associated with high rates of venous thromboembolism has been described in patients with severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) infection. These rates have currently not been described during extracorporeal membrane oxygenation in comparison to other viral pneumonias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Retrospective observational study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Single high-volume tertiary critical care department at a university hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Patients 16 years old or greater receiving venovenous extracorporeal membrane oxygenation between March 1, 2020, and May 31, 2020, with coronavirus disease 2019 were compared with a cohort of patients with influenza pneumonia between June 1, 2012, and May 31, 2020.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>The rates of venous thromboembolism and hemorrhage were compared in patients with coronavirus disease 2019 against a historic population of patients with influenza pneumonia who required extracorporeal membrane oxygenation. There were 51 patients who received extracorporeal membrane oxygenation due to coronavirus disease 2019 and 80 patients with influenza. At cannulation for extracorporeal membrane oxygenation, 37% of patients with coronavirus disease 2019 compared with 8% of patients with influenza had filling defects on CT pulmonary angiography (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.0001). Catheter-associated deep vein thrombosis shown on ultrasound Doppler after decannulation was present in 53% with coronavirus disease 2019 versus 25% with influenza (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.01). The rates of intracranial hemorrhage at the time of cannulation were 16% with coronavirus disease 2019 and 14% with influenza (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.8). Elevated <jats:sc>d<\/jats:sc>-dimer levels were seen in both conditions and were significantly higher in those with pulmonary thromboembolism than those without in coronavirus disease 2019 (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.02). Fibrinogen and C-reactive protein levels were significantly higher in those with coronavirus disease 2019 than influenza (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Significant rates of pulmonary thromboembolism and of catheter-associated deep vein thrombosis were seen in both viral infections but were greater in those requiring the use of extracorporeal membrane oxygenation in coronavirus disease 2019 than for influenza.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000004971","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T23:00:48Z","timestamp":1617577248000},"page":"e663-e672","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":52,"title":["A Comparison of Thrombosis and Hemorrhage Rates in Patients With Severe Respiratory Failure Due to Coronavirus Disease 2019 and Influenza Requiring Extracorporeal Membrane Oxygenation"],"prefix":"10.1097","volume":"49","author":[{"given":"Andrew J.","family":"Doyle","sequence":"first","affiliation":[{"name":"Centre for Thrombosis and Haemostasis, Department of Haematology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley J.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Centre for Thrombosis and Haemostasis, Department of Haematology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze M.","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilia","family":"Benedetti","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A.","family":"Breen","sequence":"additional","affiliation":[{"name":"Centre for Thrombosis and Haemostasis, Department of Haematology, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Camporota","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."},{"name":"Centre from Human & Applied Physiological Sciences, King\u2019s College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Retter","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Guy\u2019s & St Thomas\u2019 NHS Foundation Trust, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,5]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2020.05.049","article-title":"Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.","volume":"193","author":"Desborough","year":"2020","journal-title":"Thromb Res"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis.","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2020.04.028","article-title":"Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom.","volume":"191","author":"Thomas","year":"2020","journal-title":"Thromb Res"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"R5-20250502","first-page":"112","article-title":"The pulmonary vascular lesions of the adult respiratory distress syndrome.","volume":"112","author":"Tomashefski","year":"1983","journal-title":"Am J Pathol"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe2018629","article-title":"COVID-19, angiogenesis, and ARDS endotypes.","volume":"383","author":"Hariri","year":"2020","journal-title":"N Engl J Med"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ejim.2015.08.017","article-title":"Thromboembolic events in patients with severe pandemic influenza A\/H1N1.","volume":"26","author":"Avnon","year":"2015","journal-title":"Eur J Intern Med"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jvsv.2018.08.010","article-title":"Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.","volume":"7","author":"Obi","year":"2019","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19.","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.120.048925","article-title":"Systemic inflammatory response syndrome is a major contributor to COVID-19-associated coagulopathy: Insights from a prospective, single-center cohort study.","volume":"142","author":"Masi","year":"2020","journal-title":"Circulation"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S2213-2600(20)30328-3","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: A retrospective cohort study.","volume":"8","author":"Schmidt","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamasurg.2020.3950","article-title":"Extracorporeal membrane oxygenation for patients with COVID-19 in severe respiratory failure.","volume":"155","author":"Mustafa","year":"2020","journal-title":"JAMA Surg"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fmed.2018.00352","article-title":"Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components.","volume":"5","author":"Doyle","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MAT.0000000000000339","article-title":"Retrospective observational review of percutaneous cannulation for extracorporeal membrane oxygenation.","volume":"62","author":"Burns","year":"2016","journal-title":"ASAIO J"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1111\/bjh.16907","article-title":"Re The source of elevated plasma D-dimer levels in COVID-19 infection.","volume":"190","author":"Hunt","year":"2020","journal-title":"Br J Haematol"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome.","volume":"378","author":"Combes","year":"2018","journal-title":"N Engl J Med"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of coronavirus disease 2019.","volume":"48","author":"Iba","year":"2020","journal-title":"Crit Care Med"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehaa414","article-title":"Plasma angiotensin-converting enzyme 2: Novel biomarker in heart failure with implications for COVID-19.","volume":"41","author":"Oudit","year":"2020","journal-title":"Eur Heart J"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jth.14640","article-title":"Screening pulmonary angiogram and the effect on anticoagulation strategies in severe respiratory failure patients on venovenous extracorporeal membrane oxygenation.","volume":"18","author":"Hartley","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1097\/CCM.0b013e318265e461","article-title":"Pulmonary embolism in mechanically ventilated patients requiring computed tomography: Prevalence, risk factors, and outcome.","volume":"40","author":"Minet","year":"2012","journal-title":"Crit Care Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.2214\/AJR.09.3599","article-title":"Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection.","volume":"193","author":"Agarwal","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.4638","article-title":"1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.","volume":"238","author":"Walters","year":"2016","journal-title":"J Pathol"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV2 associated thrombosis.","volume":"18","author":"Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"e581","DOI":"10.1097\/CCM.0000000000001277","article-title":"Prevalence of venous thrombosis following venovenous extracorporeal membrane oxygenation in patients with severe respiratory failure.","volume":"43","author":"Cooper","year":"2015","journal-title":"Crit Care Med"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MAT.0000000000000539","article-title":"Incidence of cannula-associated deep vein thrombosis after veno-venous extracorporeal membrane oxygenation.","volume":"63","author":"Menaker","year":"2017","journal-title":"ASAIO J"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fneur.2018.00548","article-title":"Incidence, outcome, and predictors of intracranial hemorrhage in adult patients on extracorporeal membrane oxygenation: A systematic and narrative review.","volume":"9","author":"Fletcher-Sandersj\u00f6\u00f6","year":"2018","journal-title":"Front Neurol"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/CCM.0000000000002579","article-title":"Severe respiratory failure, extracorporeal membrane oxygenation, and intracranial hemorrhage.","volume":"45","author":"Lockie","year":"2017","journal-title":"Crit Care Med"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1164\/rccm.202005-1654LE","article-title":"Thromboprophylaxis in COVID-19: Anti-FXa-the missing factor?","volume":"202","author":"Dutt","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R34-20250502","article-title":"Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.","author":"Yin","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MAT.0000000000001004","article-title":"Evaluation of anti-Xa and activated partial thromboplastin time monitoring of heparin in adult patients receiving extracorporeal membrane oxygenation support.","volume":"66","author":"Arnouk","year":"2020","journal-title":"ASAIO J"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:19:53Z","timestamp":1746206393000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000004971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,5]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000004971","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,5]]}}}